Discover more from Pierre Kory’s Medical Musings
Informed Consent To Parents Contemplating COVID-19 Injections For Their Infants and Toddlers
Although a low percentage of toddlers have received COVID-19 injections, the U.S count has reached 879,000. Parents, inform yourselves. Your child's life and well-being depends on it.
On 2 occasions, mothers reached out to me for help with guidance around the decision to vaccinate their young children against COVID-19. They were deeply knowledgeable about many aspects of the data around the Covid “vaccines” and thus did not want their 2 and 4 year-old daughters respectively to be “vaccinated” (quotes are there because they are not traditional vaccines but the term is so commonly used, I will adopt for consistency).
Problem: both had ex-spouses who insisted that their daughter be vaccinated against COVID. One simply wanted guidance she could share with her ex to convince them not to. Another asked me to write a letter to the pediatrician so that he be fully informed before he made a recommendation to the ex-spouse. I initially wrote the letters in a few weeks ago, however this version incorporates even more updated data which further elevates the risk/benefit ratio in young children.
Pierre Kory’s Medical Musings is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
I provide an example of the letter for any parent of a toddler (or friend/relative of that parent who feels responsible to try to protect that child from such a potentially life-altering decision).
Dear Dr. Smith,
Ms. Hope Everlasting has asked me to provide guidance regarding the health risks and benefits of inoculating her four year-old daughter Faith with the COVID-19 mRNA experimental gene therapy currently existing under Emergency Use Authorization in the United States. Although this medical intervention does not meet the traditional definition of a vaccine, the term vaccine will be employed for ease of use in the below.
I held an informed consent discussion with Hope during which I provided the below data informing my recommendation.
Faith Everlasting, DOB 7-4-18, is a four-year-old healthy girl weighing 40 pounds. In a review of her birth and medical history, her birth was uncomplicated, and she exhibited normal development in all domains, has had no medical problems to date, is on no medications, has no history of any allergies, and has natural immunity to COVID-19 after a recent diagnosis on June 1, 2022, from which she has now fully recovered.
In the following, I will provide documentation of the informed consent discussion I held with Hope regarding a decision on whether to pursue COVID-19 mRNA vaccination for Faith. In the following, I solely relied on the most current, available data regarding;
efficacy of the COVID-19 mRNA vaccine in preventing illness in toddlers
risks associated with receipt of a COVID mRNA vaccine
risks of a healthy child suffering hospitalization and/or death from COVID
efficacy of the protection of natural immunity
benefits of health status in preventing severe outcomes
efficacy of COVID mRNA vaccine in preventing severe disease
efficacy of COVID mRNA vaccine in preventing transmission
efficacy of COVID mRNA vaccine in prevention of “long-haul” COVID
efficacy of alternatives to vaccination, i.e. early treatment options available
1) EFFICACY IN PREVENTION OF COVID-19
Pfizer Trial Studying COVID mRNA vaccine for children 6 months to 4 years old
Numerous groups of independent researchers, including my non-profit organization (the Front Line COVID-19 Critical Care Alliance) have strongly objected to what can be argued as one of the most serious violations of regulatory standards in the history of medication authorizations by the FDA and the CDC.
We base this judgement on the following:
First, it must be recognized that the pediatric clinical trials for the COVID vaccines were too small (the booster trial for 5-to-11-year olds had 140 participants) or the follow-up period too short (the trial in the 6 month to 4 year-olds were followed for 6 weeks only) to detect safety signals for serious adverse events–especially for a recipient population in the tens of millions.
Pfizers clinical trial studying a 3 dose series of COVID mRNA vaccines in 6 month to 4 year-olds:
1) The trial recruited 4,526 children. 3,000 did not make it to the end of the trial. This is a highly disturbing finding and is almost unprecedented to have this number of subjects (2/3) drop out of any trial. This level of drop-out should have negated the value of any findings.
2) The trial defined “severe covid” as an increased heart or respiratory rate. There were 6 cases in the vaccinated group and only one in the unvaccinated group. The only child hospitalized in the trial had a fever and a seizure. They were in the vaccinated group.
3) In the 3-week period between the first and 2nd doses in this trial, 34 of the vaccinated children contracted COVID, while only 13 in the unvaccinated group contracted COVID.
4) When comparing cases one week after the 3rd dose, only 10 cases occurred, with 7 in the placebo group and 3 in the vaccinated group. Thus, a total of ten cases out of 4,526 children enrolled was the entire extent of the used to support authorization.
In light of this paucity of data, their own comment on efficacy was worded as follows: “Vaccine efficacy post Dose 3 cannot be precisely estimated due to the limited number of cases accrued during blinded follow-up, as reflected in the wide confidence intervals associated with the estimates.”
More disturbing is that safety was only monitored for 6 weeks before they decided to vaccinate the children in the placebo group, an unprecedented lack of follow-up for both short term and long-term safety.
The trials for children 2 through 4 years old failed to meet FDA-specified requirements for COVID vaccine EUAs. The vaccines did not show 50% efficacy nor meet the required 30% lower bound with a 95% confidence interval. Given these data, there is no support for the proposal to use a product and schedule that failed FDA‘s established criteria in its clinical trials.
Any proposal to add further doses (boosters) later in order to provide a fleeting efficacy boost to the Pfizer vaccines for preschoolers would have to ignore the fact that that the Pfizer shots in the 5-11 year range led to very poor efficacy; 31% according to the CDC and 12% after 7 weeks according to a massive database comprising over 1.3 million children (365,000 of whom were vaccinated) from the NY Department of Health. Five to 11-year-old children dropped into the negative efficacy by 8 weeks after receiving the second dose. See Figure below.
The study above was the largest COVID vaccine efficacy study in children ever published, using the highest quality, official data from NY state. There was a large, linear drop in efficacy seen with each successive week following full vaccination. Extremely narrow confidence intervals confirm the validity of these data. By 8 weeks following their second dose, vaccinated children were placed at higher risk of developing COVID than unvaccinated children. By 9 weeks, their risk was even higher. Despite illogical attempts to minimize this finding, the fact is that being vaccinated placed these children in a higher risk category for a COVID infection than if they had never been vaccinated.
As as a result of such a severe violation of traditional regulatory approval standards:
The state of Florida recommends against COVID vaccines for children.
The Publix Supermarket chain announced that they would not offer COVID vaccines to young children.
On June 22, the Danish Health Ministry held a COVID Press Conference; the General Director Søren Brostrøm said, “With the knowledge we have today, we did not get much out of having children vaccinated against coronavirus last year.” When asked asked if it was a mistake to vaccinate children, he answered, “With what we know today: yes. With what we knew then: no, was the answer.”
7 nations have suspended COVID-19 vaccines for younger age groups due to risks of myocarditis.
Sweden, Finland, France, and Germany suspended Moderna for under 30 years old
Denmark suspended Moderna vaccine for under 18 years old
Taiwan suspended 2nd Pfizer vaccine for ages 12-17
More recent data studying the impacts of vaccines in the general population report alarming findings of inefficacy:
A JAMA-published study that shows that the number of reinfections increases with every vaccine dose received.
In a recent study published in the prestigious New England Journal of Medicine, they reported that individuals fully vaccinated and boosted against COVID-19 recover markedly more slowly from the illness and remain contagious for lengthier periods of time compared to unvaccinated persons. Further, people that are vaccinated remain five times as contagious as those who are unvaccinated ten days after SARS-CoV-2 infection.
The original Moderna clinical trial data, which should have been available to regulatory agencies at least since the Moderna package was presented for licensure, reveals that while 93% of unvaccinated controls produced detectable SARS-CoV-2 anti-nucleocapsid antibody after infection, only 40% of the vaccinated produced this antibody after infection. Most of the vaccinated failed to mount the expected immune response. This is probably why Dr. Marco Cavaleri of the European Medicines Agency "warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency." It is probable that the more doses of these vaccines you receive, the less broad immunity you will develop, even after getting infected. Why subject children to the long-term risk of damaging their immunity to coronaviruses by authorizing vaccines for the youngest children?
Walgreens pharmacies perform rapid antigen COVID tests and report weekly on the results, based on the number of vaccine doses received and the date the most recent vaccination was obtained. The results reveal that receiving a 2nd or 3d dose within the past 5 months leads to a comparable positivity rate as being unvaccinated (21.8-26.2%). However, receiving 2 or 3 doses more than 5 months ago leads to the highest positivity rates (33.5-38.4%). This is further supportive evidence that efficacy falls into negative territory several months after vaccination. See the chart below.
Stanford researchers found that “prior vaccination with Wuhan-Hu-1-like antigens followed by infection with Alpha or Delta variants gives rise to plasma antibody responses with apparent Wuhan-Hu-1-specific imprinting manifesting as relatively decreased responses to the variant virus epitopes compared with unvaccinated patients infected with those variant viruses.”
From a Public Health England vaccine surveillance report in the U.K., government researchers asserted (p. 23) that their serology tests were underestimating the number of people with prior infection due to recent observations from UK Health Security Agency (UKHSA) surveillance data that “N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.”
Dr. Paul Offit, Chair of the FDA Vaccine Advisory Board conceded in a letter to the New England Journal of Medicine that there is a real concern of the shots inducing a form of immune suppression known as original antigenic sin.
In this peer-reviewed paper, they found that at the country-level (and U.S county level), there appears to be no discernable relationship between the percentage of the population fully vaccinated and new COVID-19 cases as seen below. In fact, the rising slope of the relationship in both graphs below suggest that mass vaccination policies may paradoxically lead to more cases, with Israel serving as a worrying outlier.
A study prepared by Humetrix for the Department of Defense called "Project Salus," monitored 20 million Medicare beneficiaries from January to August of 2021 and found that the vaccinated share of the COVID hospitalizations rose steadily with both vaccines after three to four months and sharply after six months (as the Israelis found). By late July, 71% of all cases and 61% of all hospitalizations were among vaccinated individuals.
According to Cornell University’s faculty, an outbreak in December of 2021 which forced the school to switch to online learning was driven exclusively by the vaccinated. "Virtually every case of the Omicron variant to date has been found in fully vaccinated students, a portion of whom had also received a booster shot," said Vice President for University Relations Joel Malina in a statement.
On December 31, 2021, the UK’s Office of National Statistics released an “Infection Survey” of 1,701 individuals who tested positive for COVID between Nov. 29 and Dec. 12, of whom 115 tested positive for the Omicron variant. The agency found a clear correlation between the number of vaccinations and the likelihood of an Omicron-positive result. The odds ratio of testing positive for Omicron with two vaccinations was 2.26; for the triple-vaccinated, it was 4.45.
According to this U.K. health surveillance report, roughly 95% of those over 70 are double-vaccinated and about 90%-93% of the age cohorts over 70 are boosted. Just 1.6% of the senior cases between weeks 7 and 10 of this year were among the unvaccinated, which is below the 5% share of the population they compose. The triple-boosted actually made up 90% of the cases.
The respected Robert Koch Institute reported that among the 4,206 Germans infected with Omicron for whom their vaccination status was known, 95.58% were fully vaccinated. More than a quarter of them had booster shots. Given that the overall background rate for vaccination in Germany is 70%, this suggests an -87% effectiveness rate against Omicron.
As of Dec. 31, 2021, in Denmark, 89.7% of all Omicron cases were among the fully vaccinated with just 8.5% of all cases in Denmark among the unvaccinated, according to the Statens Serum Institut. Overall, 77.9% of Denmark was fully vaccinated at the time, and Omicron is more prevalent among younger people for whom there is a greater unvaccinated pool, which again support a negative efficacy. Even for non-Omicron variants, the unvaccinated composed only 23.7% of the cases.
In summary, the most salient aspects of the above data indicate a rapid and higher likelihood over time of suffering COVID-19 if vaccinated. The two most likely explanations for this finding are that:
the current mRNA vaccines were formulated using the genetic sequences of the original “Wuhan” strain of SARS-CoV2 from over 2 years ago. Given SARS-CoV2 is a highly mutagenic virus, efficacy in protection rapidly wanes.
recent studies show that COVID-19 vaccinated individuals develop significant negative impacts in immune system protection and surveillance.
2) RISKS ASSOCIATED WITH RECEIVING THE COVID mRNA VACCINE
Increasing numbers of scientific manuscripts detail mechanisms underlying the potential causes of significant morbidity, in particular the immune suppression leading to the increased risks of infection as detailed in this post, as well as increased rates of cancer in those vaccinated that doctors are reporting.
One of the Adverse Effects from Pfizers post marketing study was the development of "anti-sperm antibodies" -- referring to damage to male sperm.
Most concerning for the future health of a young child is that adding the above finding of the possibility of anti-sperm antibodies to the severely increased rates of spontaneous abortion in pregnancy, leads to disturbing implications of decreased fertility among the vaccinated. This appears to have become a reality. Recent reports of unprecedented drops in birth rates from countries all over the world validate this implication in that, unless alternative explanations for the widespread decrease in fertility can be found, as per long standing regulatory standards, the cause must be assumed to be COVID mRNA vaccination until proven otherwise.
Other concerns abound: a group of independent German scientists found toxic components—mostly metallic—in all the COVID vaccine samples they analyzed, “without exception” using modern medical and physical measuring techniques.The following metallic elements were found in the vaccines. They have recently submitted their report to the German government.
Alkali metals: caesium (Cs), potassium (K)
Alkaline earth metals: calcium (Ca), barium (Ba)
transition metals: cobalt (Co), iron (Fe), chromium (Cr), titanium (Ti)
Rare earth metals: cerium (Ce), gadolinium (Gd)
Mining group/metal: aluminum (Al)
Carbon group: silicon (Si) (partly support material/slide)
Oxygen group: sulphur (S)
A new peer-reviewed study in eLife Sciences, conducted by the Department of Gene Therapy at the University of Ulm, Germany found concerning evidence of contamination of AstraZeneca vaccine batches by proteins derived from the human cell lines in which they were produced. This may have reduced the effectiveness of the vaccine by lowering the immune response. Moreover, it may have caused a variety of adverse reactions. The editor of the journal correctly notes that “this paper is important because lot purity and processing of vaccines is rarely scrutinized in the scientific realm, and instead is typically analyzed only by the companies themselves.”
Furthermore, multiple studies have suggested that vaccinating after infection increases the risk of vaccine-induced side effects such as myocarditis. A new study published in the Nature journal Scientific Reports adds to the body of vaccine myocarditis research, this time showing an association between mass vaccination and increased emergency cardiovascular events.
Israel - In a recently leaked recording, it was discovered that a researcher hired to study vaccine injuries reported back to the Israeli Ministry of Health that his findings establish a causal relationship between injuries, deaths and the vaccines and warned them that they could be exposed to lawsuits.
The risks demonstrably outweigh the benefits of COVID vaccination in children. A study out of Hong Kong showed one out of every 2,700 12-17-year-old boys are diagnosed with myocarditis following the 2nd dose of Comirnaty vaccine (37 per 100,000 vaccinated). A study from Kaiser found the same rate of myocarditis in 12-17-year-old American boys, 1/2700.
9) While CDC is saying that myocarditis is a mild disease, cardiologists know otherwise. The CDC’s own preliminary data, reported at the February 4 ACIP meeting, revealed that nearly half of the young people diagnosed with myocarditis still had symptoms 3 months later, and 39% had their activity restricted by their physician. We know this serious adverse event frequently occurs in teenagers. But no one knows how often it occurs in younger children. This is of significant concern for babies and younger children.
Again, it also must be noted that 7 nations have suspended COVID-19 vaccines for younger age groups due to risks of myocarditis.
· Sweden, Finland, France, and Germany suspended Moderna for under 30 years old
· Denmark suspended Moderna vaccine for under 18 years old
· Taiwan suspended 2nd Pfizer vaccine for ages 12-17
It does not meet the risk-benefit standard of 21 U.S. Code § 360bbb–322 “the known and potential benefits of the product, when used to diagnose, prevent, or treat such disease or condition, outweigh the known and potential risks of the product.”
Some children likely will die and others will be permanently injured from these vaccines based on reporting to the current VAERS database. The latest data shows a total of 1,287,595 reports of adverse events from all age groups following COVID vaccines, including 28,532 deaths and 235,041 serious injuries between Dec. 14, 2020, and May 27, 2022.
There are no long-term safety data for COVID vaccination of young children, and the proposal is to vaccinate children under an Emergency Use Authorization. These facts establish that vaccinating small children for COVID will be an experiment, not a standard medical procedure. If we miss significant side effects that occur in babies and toddlers, the health trajectories of their lives could be changed.
There is no available care for children injured by COVID shots. There is no way to remove the spike protein and other toxic byproducts of vaccination, which may be produced for a considerable period of time following inoculation of messenger RNA. The science and medicine have not yet developed, and most families will be unable to cover the costs of potential catastrophic injuries. The federal government’s Countermeasures Injury Compensation Program has not compensated a single person injured by COVID vaccines.
Three weeks ago, FDA authorized booster doses of Pfizer vaccine for 5-11-year-olds without convening a VRBPAC meeting or providing any public discussion of the evidence supporting the booster. Dr. Peter Marks, the Director of FDA’s Center for Biologics told the VRBPAC in April that the FDA’s issuance of an EUA for a second booster in adults was a “stopgap measure”-- the implication being there was no scientific evidence to support that booster. Has FDA given up even the appearance of a scientific evaluation before issuing more EUAs for COVID vaccines?
In this published paper analyzing data from the pivotal clinical trials used to support the novel mRNA vaccines (i.e. Moderna, Pfizer, and Janssen), Classen compared “all cause severe morbidity,” defined as “severe infections with COVID-19 and all other severe adverse events between the treatment arms and control arms respectively.” His analysis found a statically significant increase in all cause severe morbidity occurred in the vaccinated group compared to the placebo group.
In the documents related to a recent FOIA request, in the Pfizer informed consent document (p. 5) it was revealed that the company recognized the risk of myocarditis to be as high as 1 in 1,000. In 2022, with many fewer vaccines administered compared to 2021, the rate of myocarditis reports to VAERS is averaging 245% higher than last year. The myocarditis is overwhelmingly found in children.
In this paper by Walach et al, they calculated the Number Needed to Vaccinate (NNTV) to prevent one death from a large Israeli field study. They then accessed the Adverse Drug Reactions database of the Dutch National Register (Lareb) to extract the number of cases reporting severe side-effects and the number of cases reporting fatal side-effects.
· They found the NNTV to be between 200 and 700 to prevent one case of COVID-19 by Pfizer’s mRNA vaccine product.
· The NNTV to prevent one death was between 9,000 and 100,000 (95% confidence interval), with 16,000 as a point estimate (as you will see below, for younger healthy people, this estimate would tend to the higher end of a NNTV of 90,000-100,000 to prevent a single death).
· They calculated that for every 6 deaths prevented by vaccination, there were approximately 4 deaths reported associated with vaccination, yielding a potential risk/benefit ratio of 2:3 (note that deaths are consistently under-reported to such databases, thus a more accurate risk/benefit ratio for death would likely be inverted).
· They concluded that, “although causality between individual reports of adverse events and vaccination has not been established, these data indicate a lack of clear benefit, which should cause governments to rethink their vaccination policy”.
In this published paper by Jessica Rose, a world-expert analyst of the VAERS database, she found that, based on the ratio of expected severe adverse events to observed adverse events in VAERS for a number of conditions, the “underreporting factor (URF)” for COVID vaccine-associated deaths was 31. Using this URF for all VAERS-classified severe adverse events, as of October 2021, vaccines were associated with 205,809 deaths, 818,462 hospitalizations, 1,830,891 ER visits, 230,113 life-threatening events, 212,691 disabled and 7,998 birth defects."
This paper by Ronald Kostoff et al was retracted despite passing peer-review. However, in a personal review of the correspondence between the author and Journal Editor, neither I nor my colleagues were able to find a valid criticism of the underlying data analysis or conclusions. Therefore, I have incorporated this valuable study whereby they used a novel, best-case scenario, cost-benefit analysis which showed conservatively that there were five times the number of deaths attributable to each inoculation vs. those attributable to COVID-19 in the most vulnerable 65+ demographic. The risk of death from COVID-19 decreased drastically as age decreases, and the longer-term effects of the inoculations on lower age groups “may increase” their risk-benefit ratio (although this has not been demonstrated to date as can be seen below).
In this review of autopsy study data, they found that after mRNA vaccination, there was
rapid distribution of the vaccine through the bloodstream,
widespread spike protein expression, prominently in blood vessels, and
autoimmune-like inflammation and organ damage.
As of April 22, 2022, in the United States alone 5,309 cases of myocarditis, 782,665 adverse events, 151,796 severe adverse events, and 14,613 deaths have been recorded in the Vaccine Adverse Event Reporting System following COVID-19 vaccination in the USA. It should be appreciated that the VAERS databases’s main limitation is that of underreporting, by a factor of at least 30-fold. The most concerning implication of under-reporting is in regards to the exponential increases in actual reports of death after vaccination in the past year compared to prior years of all vaccines combined.
Even more damning is the temporal relationship of these reports to the date of the individual’s vaccination, which some authorities have attempted to dismiss as simply representing “background” deaths. The fact that the reporting of deaths decrease over time from date of vaccination (seen below), infers a worrying causal relationship whereas erroneously reported “background deaths” would instead appear in similar numbers each subsequent day after the date of vaccination.
Statisticians and analysts working with the Vaccine Safety Research Foundation (VSRF) have estimated the total number of deaths in the U.S caused by the COVID-19 vaccines based on the numbers reported to the U.S Vaccine Adverse Event Reporting System. In their white paper, they employed 9 different statistical prediction models and found that as of December of 2021, total deaths associated with the vaccines ranged from 148,000 to 216,000. Using the same methodology for the 14,613 COVID-19 vaccine associated deaths in the U.S reported as of May 16, 2022, the updated point estimate is approximately 599,000 deaths. The data and conclusions from these publications above provide support for identifying the vaccination campaign as the primary cause of the massive increases in Life Insurance claims among working-age Americans beginning in the second half of 2021, as will be detailed below.
· increases of over 25% in the number of ambulance calls in response to cardiac arrests (CA) and acute coronary syndromes (ACS or “heart attacks”) for young people people in the 16–39 age group during the COVID-19 vaccination rollout in Israel (January–May, 2021) compared with the same period of time in prior years (2019 and 2020).
· a robust and statistically significant association between the weekly CA and ACS call counts and the rates of 1st and 2nd vaccine doses administered to this age group. Note they found no observed statistically significant association between COVID-19 infection rates and the CA and ACS call counts.
· findings that aligned with previous studies showing that increases in overall CA incidence were not always associated with higher COVID-19 infections rates at a population level, and that the stability of hospitalization rates related to myocardial infarction throughout the initial COVID-19 wave compared to pre-pandemic baselines in Israel.
· findings that mirrored reports of increased emergency department visits with cardiovascular complaints during the vaccination rollout in Germany as well as increased EMS calls for cardiac incidents in Scotland.
In line with the above, as a result of a FOIA application in the state of Massachusetts, an analysis of the now publicly available death certificate data found that during 2020, the predominant cause of rises in all cause mortality were due to “respiratory causes,” (i.e. excess mortality from COVID-19) while in 2021, the predominant causes were “cardiovascular.” The analyst concluded, “the official Massachusetts database of death certificates contains proof that C19 vaccines killed thousands of people in Massachusetts in 2021.”
Equally alarming are the massive rise in deaths among healthy, young professional athletes from around the world. Since the vaccination campaign was initiated, and as of June 4, 2022, there were approximately 1,090 athletes that suffered a cardiac arrest, with 715 of them dying as a result. The majority of arrests occurred in competition or training. The frequency of these events in comparison to historical data is highly concerning. In a 2009 review of professional athletes deaths, published in a prominent European Cardiology journal, they found that from 1966 to 2004, there was an average of only 29 sudden athlete deaths per year worldwide. Compare this number to just the month of January 2022 alone where 127 collapses and 87 deaths among professional athletes were reported. Overall, these athlete deaths reflect an approximately 22-fold increase in the year after the introduction of COVID vaccines, to date unexplained by other identifiable causes.
The CDC data provided in this article shows the timing of the start and the steady rise in all-cause mortality of working-age adults in the U.S, both overlapping with the start of the mass vaccination campaign. Although alternate causes of this historic rise in death have been considered, (i.e. COVID deaths, deaths of despair etc), the number of deaths from these causes is insufficient to explain the overall rise.
On Feb. 10, the Israeli Health Ministry published the results of a survey of adverse events among roughly 2,000 random Israelis who received booster shots. Although many could be thought of as minor, it is concerning that 51% of the women and 35% of the men who experienced a side effect reported that, as a result, they had difficulty performing daily activities. A total of 4.5% of those who received booster doses reported neurological side effects.
3) RISKS OF A HEALTHY CHILD SUFFERING HOSPITALIZATION AND/OR DEATH FROM COVID
Current data shows that children have a 99.995% recovery rate, and a body of medical literature indicates that almost zero healthy children under five years old have died from COVID. Further, only a fraction of the rare child deaths were due to COVID and these do not accord with pediatric COVID death rates from other countries. The NY Times has reported that the CDC has chosen to conceal the number of Americans who died due to COVID, even though the data are found on death certificates.
Peer-Reviewed and Health Agency Data
· A study from Johns Hopkins that monitored 48,000 children diagnosed with COVID showed a zero-mortality rate in children under 18 without co-morbidities. The Wall Street Journal reported on this in their article “The Flimsy Evidence Behind the CDC’s Push to Vaccinate Children.”
· Data from England and Wales, published by the UK Office of National Statistics on January 17, 2022, revealed that throughout 2020 and 2021, only one (1) child under the age of 5, without co-morbidities, had died from COVID in the two countries, whose total population is 60 million.
· The CDC published data stating that 203 children aged 6 months through 4 years have died “with” COVID since the start of the pandemic, averaging 85 deaths in this age group “with” COVID yearly. I must emphasize again that only a fraction of the rare child deaths were due to COVID and these do not accord with pediatric COVID death rates from other countries.
· It is well known that hospitalizations and deaths with COVID have been misattributed as hospitalizations and deaths due to COVID by federal health agencies, leading to numbers of severe cases and deaths that have been disputed by US physicians investigating them, and which do not accord with the mortality rates for children in other nations. CDC now publishes its COVID mortality data as deaths with COVID, blatantly exaggerating COVID-caused morbidity and mortality.
· According to the CDC and the New York Times, it has been over 3 months (since February 28, 2022) during which there has been fewer than one US child per 100,000 children hospitalized daily for COVID. Contrast this number with the 37 children per 1000,00 who will contract myocarditis from the vaccine as detailed below.
· According to the CDC data tracker, less than 0.1% of all US deaths that have occurred “with” COVID have occurred in children aged 0 through 4.
· Strong evidence that newer variants of COVID-19 (Omicron) pose dramatically reduced risks to young children was published in the April 1, 2022, JAMA Pediatrics by Wang et al. Using a huge US medical database, they were able to match children aged under 5 who were infected with an Omicron variant with those who were infected with a Delta variant. Children with Omicron were only 35% as likely to require an ICU admission and only 15% as likely to require mechanical ventilation as same-aged children who had been sick due to earlier delta variants.
Below are the June 8, 2022, New York Times graphs for the a recent number of US patients in hospitals, ICUs, and suffering deaths attributed to COVID. The numbers of patients in ICUs and dying each day ascribed to COVID are close to the lowest numbers since the start of the pandemic. Given that the CDC extrapolated that 95% of Americans already have partial to complete immunity, while we are at historic low levels for severe COVID disease, it should be clear that there is no need to vaccinate anyone now.
4) EFFICACY OF THE PROTECTION FROM NATURAL IMMUNITY
Faith’s natural immunity provides robust protection, not only from contracting COVID-19 a second time, but also against hospitalization and death.
Most children are already immune. Natural immunity is superior to vaccine-induced immunity, and vaccinating the already immune is superfluous and potentially harmful as per this study. Further, CNBC reported in April 2022, “An estimated 95% of the U.S. population ages 16 and older had developed antibodies against the virus either through vaccination or infection as of December, according to a CDC survey of blood donor samples.” CDC earlier said over 75% of children already have partial or full immunity to COVID. I will remind you that Faith recently recovered from COVID.
The CDC recently reported that since October of 2021, persons who survived a previous infection had lower case rates than persons who were vaccinated alone.
The most recent review of data supporting the protection of natural immunity, compiled from over 150 research studies, found that natural immunity provided equal or superior protection against not only contracting the disease, but also against hospitalization and death.
Further, vaccinated individuals are far more likely to get re-infected with COVID compared to those with natural immunity as evidenced below:
A new preprint study from Bangladesh found that among 404 people re-infected with COVID, having been vaccinated made someone 2.45 times more likely to get re-infected with a mild infection, 16.1 times more likely to get a moderate infection, and 3.9 times more likely to be re-infected severely relative to someone with prior infection who was not vaccinated. Although overall re-infections were rare, vaccination was a greater risk factor of re-infection than co-morbidities.
A new study from Harvard, Continued Effectiveness of COVID-19 Vaccination among Urban Healthcare Workers during Delta Variant Predominance, tracked vaccinated and unvaccinated Massachusetts healthcare workers and showed 0 infections in 74,557 person-days for previously infected patients compared to 49 infections out of 830,084 person-days for fully vaccinated patients.
A study published in the New England Journal of Medicine assessed a cohort of 1,304 patients meeting a very strict definition of “re-infection.” In this cohort, there were no deaths and no ICU admissions during reinfections while 7 deaths and 28 ICU admissions occurred during the primary infections. Overall, there was a statistically significant 90% reduction in the composite outcome of severe, critical, or fatal disease during reinfections.
In summary, given Faith recently recovered from COVID-19, there is no ethical justification for an unnecessary vaccination that will put her at an elevated risk of both vaccine harms and re-infections.
5) BENEFITS OF CURRENT HEALTH STATUS IN PREVENTING SEVERE OUTCOMES
Faith is a healthy 4 year-old girl of normal body weight. Her youth and body habitus combined with an absence of co-morbidities essentially ensures that she has a near-nil risk of a severe outcome. I base this on data compiled during a prior, more deadly variant where the CDC published a report on the incidence of death from COVID-19 prior to September of 2021 in people less than 21 years of age. At the time of that report, 190,000 deaths from SARS-CoV-2 had been recorded in the general population. Although people less than 21 years of age represent 26% of the population, only 0.08% (121) of all COVID-19 deaths were reported in this age group. In other words, more children died from influenza during the previous epidemic season than from SARS-CoV-2.
Several other observations were of interest:
about 75% of those under 21 who died had at least one underlying medical condition; 45% had two or more conditions.
minority groups were disproportionately represented among the deaths in young people. Among those who died, 45% were Hispanic, 29% were black, and 4% were American Indian or Alaskan Native persons. Although Hispanic, Black and Native populations represent 41% of the U.S. population less than 21 years of age, these groups accounted for 75% of the deaths. Faith is Caucasian.
In July of 2021, Dr. Marty Makary of Johns Hopkins University and Editor in Chief of MedPage today, reported that over the course of the pandemic, 49,000 Americans under the age of 18 had died of all causes, according to the CDC. Only 331 of those deaths were from COVID — less than half as many as that died of pneumonia. The risk of children was dramatically smaller still than that CDC baseline; according to one, much-cited paper, the infection fatality rate for those aged 5 to 9 is less than 0.001 percent. A large new study from the U.K. examining the fatality rate among all those under 18 found it only fractionally higher — 0.005 percent. Overall, 126,000 Brits have died of COVID since the onset of the pandemic; just 26 of those were under the age of 18.
These data presented above must be further interpreted in the context of the current Omicron variant, a variant with markedly lower risk of leading to hospitalization and and/or death among the unvaccinated.
6) EFFICACY OF COVID VACCINES IN PROTECTION FROM SEVERE DISEASE
CDC data shows that there is no statistically valid evidence that they prevent severe disease or deaths in children. Current mRNA injections were formulated based on the original Wuhan strain and were not tested for benefits against current variants in clinical trials. Which begs the question as to what can be accomplished by vaccinating small children with an outdated vaccine. Further, amongst all ages, CDC found that natural immunity offerred equal protection against hospitalization.
In Ireland, in March of 2022, during the milder Omicron variant wave, there were more people in Irish hospitals than at any point in the previous 12 months. This occurred despite the fact that nearly 95% of all adults in Ireland are fully vaccinated, and nearly 100% of seniors are vaccinated and boosted.
In Scotland, on page 29 of their recent national COVID-19 report, the data revealed that the vaccinated were dying and being hospitalized at higher rates than the unvaccinated. Note that Scotland has since made the decision to no longer publish these comparative data for “concerns that they are being misinterpreted”. Although it is true, as I noted above, that numerous variables beyond vaccination status may contribute to explaining these differences, I find it troubling (similar to the Department of Defense actions mentioned above) that the decision to stop publishing these data occurred only after a negative efficacy against severe disease and death was found.
In Israel, the Director of a major hospital recently declared that the fully vaccinated are not protected against severe illness.
NSW Health in New South Wales, the most populated of Australian states at 8.1 million inhabitants, reported that 97 out of 98 COVID-19 deaths occurring over the previous two weeks involved fully vaccinated persons. Moreover, those that had three doses appeared most at risk for hospitalization admission, ICU transfer, and death.
These data are consistent with the recent report published in the New York Times which stated “despite strong levels of vaccination among older people, COVID killed them at vastly higher rates during this winter’s Omicron wave than did last year, preying on long delays since their last shots and the variant’s ability to skirt immune defenses.” I must add that these higher rates of death in the elderly are also seen in the boosted.
The conclusion of a recent Danish study in the prestigious Lancet found that in long-term follow-up of over 74,000 adult participants in the Moderna and Pfizer trials there was no all-cause mortality benefit from the two mRNA shots.
In a recent, large Veterans Administration study, investigators discovered disturbing evidence: by month six after a SARS-CoV-2 infection, beyond the first 30 days of illness, vaccinated persons with breakthrough infections were at higher risk of death (hazard ratio (HR) = 1.75, 95% confidence interval: 1.59,1.93).
Thus, in terms of benefits, based on the most up-to-date data, the current crop of mRNA vaccines against Omicron confer either rapidly waning efficacy or negative efficacy, and not only do they no longer protect against severe disease, my interpretation of these data is that they appear to be raising the risk of severe disease and death. I would advise extreme caution given that, currently, in the U.S, the prevalence of the B4/5 variant appears to be doubling every week in the past month, now comprising approximately 8% of cases.
In regards to the current variant B4/5, my rapidly evolving clinical experience and those of my network of colleagues is that the vaccinated are contracting more severe illness and are less quickly responding to combination anti-viral and anti-inflammatory therapies.
7) BENEFITS IN REDUCING TRANSMISSION TO OTHERS
Current data do not support this claim. The CDC Director herself has reported that vaccinated individuals are now well known to carry equal or greater viral loads than the unvaccinated, and thus transmit at equal or higher rates, for physiologic reasons detailed above, most concerning being the negative efficacy of the vaccines against Omicron. This has also been reported by seminal nosocomial outbreak papers by Chau et al. (Health care workers (HCW) in Vietnam), the Finland hospital outbreak (spread among HCWs and patients), and the Israel hospital outbreak (spread among HCWs and patients).
A new large study from Quatar in the New England Journal of Medicine by Weil Cornell Medicine found that the Pfizer vaccine protection waned after four months. By seven months, when adjusted for those who already had prior infection, the Pfizer shot was -4% effective against transmission. Also, effectiveness against asymptomatic infection was -33% after seven months, which suggests that the vaccinated become more likely to spread COVID-19 over time.
8) BENEFITS IN REDUCING THE RISK OF LONG-HAUL COVID SYNDROME
Again, from the large Veterans Administration study, investigators discovered disturbing evidence: by month six after a SARS-CoV-2 infection, vaccinated persons with breakthrough infections were at higher risk of long COVID (HR = 1.50, 95% CI: 1.46, 1.54). When including the earlier time periods, the COVID-19 vaccines only reduced the risk of long COVID by approximately 15% compared to the unvaccinated, a level of estimated protection far less than the increased risk of death found in the same study as mentioned above.
Summary and Recommendations
Based on Faith’s current robust health status, natural immmunity, normal body habitus, and normal development, she has a near-nil risk of the most severe outcomes from COVID. Further, the totality of current evidence finds either a negligible, highly transient efficacy in protection against COVID-19 or a rising negative efficacy in protection from both COVID and its more severe outcomes.
Most importantly, given the highly concerning, excessive rates of adverse events, disabilities, and deaths found in the vaccine trials data and in association with the mass vaccination campaign, it is my professional opinion that the risks of COVID-19 mRNA vaccination for Faith far outweigh the negligible or “adverse” efficacy currently being measured.
Further, the unexplained sudden, statistically and historically unprecedented decreases in birth rates timed from approximately 9 months after the height of vaccine rollouts in numerous countries around the world suggest an extremely high risk of a negative impact on her future reproductive health.
Vaccinating children who you know are likely to be placed at higher risk from COVID and of toxic side-effects and even death as a result of vaccination is not “public health;” it is medical negligence. This is an unprecedented proposal not backed by current data, logic, or ethics. I therefore offer my strongest recommendation that she avoid COVID-19 mRNA vaccination… at all costs given that her very life depends on it.
Feel free to call or write with any questions to firstname.lastname@example.org.
Pierre Kory, MD, MPA
Internal Medicine , Pulmonary Diseases, Critical Care Medicine
I just want to say how much I appreciate all the subscribers to my Substack, and especially the paid ones! Your support is so greatly appreciated.
P.S. I opened a tele-health clinic providing care not only in the prevention and treatment of acute COVID, but with a specialized focus on the study and treatment of both Long-Haul and Post-Vaccination injury syndromes. If anyone needs our help, feel free to visit our website at www.drpierrekory.com.
P.P.S. I am getting professional help (hah!) to write a book about what I have personally witnessed and learned during Pharma’s historic Disinformation war on ivermectin. Pre-order here for:
Pierre Kory’s Medical Musings is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.